Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Haugen

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Christian Nurse International|January 1, 1995
Learning, learning, forever learningR Haugen
Cancer|October 15, 2016
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?Bryan R Haugen
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|September 24, 2004
Redifferentiation therapy in advanced thyroid cancerBryan R Haugen
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 2, 2012
Radioiodine remnant ablation: current indications and dosing regimensBryan R Haugen
Seminars in Surgical Oncology|January 16, 1999
Management of the patient with progressive radioiodine non-responsive diseaseB R Haugen
Best Practice & Research. Clinical Endocrinology & Metabolism|November 28, 2009
Drugs that suppress TSH or cause central hypothyroidismBryan R Haugen
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablationBryan R Haugen
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Does the metabolic activity of metastatic thyroid carcinoma correlate with prognosis?Bryan R Haugen
Thyroid : Official Journal of the American Thyroid Association|December 29, 2000
The risks and benefits of radioiodine therapy for thyroid carcinoma remain somewhat undifferentiatedB R Haugen
Reviews in Endocrine & Metabolic Disorders|November 14, 2001
Initial treatment of differentiated thyroid carcinomaB R Haugen
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Christian Nurse International|January 1, 1995
Learning, learning, forever learningR Haugen
Cancer|October 15, 2016
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?Bryan R Haugen
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|September 24, 2004
Redifferentiation therapy in advanced thyroid cancerBryan R Haugen
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 2, 2012
Radioiodine remnant ablation: current indications and dosing regimensBryan R Haugen
Seminars in Surgical Oncology|January 16, 1999
Management of the patient with progressive radioiodine non-responsive diseaseB R Haugen
Best Practice & Research. Clinical Endocrinology & Metabolism|November 28, 2009
Drugs that suppress TSH or cause central hypothyroidismBryan R Haugen
The Journal of Clinical Endocrinology and Metabolism|August 5, 2004
Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablationBryan R Haugen
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Does the metabolic activity of metastatic thyroid carcinoma correlate with prognosis?Bryan R Haugen
Thyroid : Official Journal of the American Thyroid Association|December 29, 2000
The risks and benefits of radioiodine therapy for thyroid carcinoma remain somewhat undifferentiatedB R Haugen
Reviews in Endocrine & Metabolic Disorders|November 14, 2001
Initial treatment of differentiated thyroid carcinomaB R Haugen
Pageof 18